Marcus Lee, MD
Family Medicine · Tullahoma, TNNPI 1457364077
Payments from drug & device makers
Across 641 payments — averaging $2336.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.1M
- AbbVie$237K
- Novo Nordisk AS$121K
- GSK$57K
- Chiesi USA, Inc.$11K
- AstraZeneca$5K
- plus $2K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 108 | $1,065,441 |
| AbbVie(2 entities) | 57 | $237,040 |
| Novo Nordisk AS | 347 | $121,058 |
| GSK | 9 | $57,125 |
| Chiesi USA, Inc. | 1 | $10,500 |
| AstraZeneca | 12 | $4,716 |
| Novo Nordisk | 36 | $430 |
| Johnson & Johnson | 15 | $156 |
| Bayer | 7 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $109 |
| Amgen | 6 | $95 |
| Boehringer Ingelheim | 4 | $74 |
| Exact Sciences | 4 | $70 |
| Merck | 4 | $65 |
| Sanofi-aventis U.S. LLC | 4 | $58 |
| Boston Scientific | 2 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| Lilly USA, LLC | 3 | $44 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 2 | $27 |
| Novartis | 2 | $24 |
| Valeritas, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Bausch Health US, LLC | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $12 |
How this compares
$1,497,421 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Tullahoma
- John AndersonTullahoma$23K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.